» Authors » Todd F Hatchette

Todd F Hatchette

Explore the profile of Todd F Hatchette including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 85
Citations 1205
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pott H, Andrew M, Shaffelburg Z, Nichols M, Ye L, ElSherif M, et al.
Open Forum Infect Dis . 2025 Feb; 12(2):ofaf058. PMID: 39968306
Background: Oseltamivir is recommended for the treatment of adults hospitalized with influenza, but adherence is often suboptimal. This may be due to doubts about the reliability of the evidence supporting...
2.
Pott H, LeBlanc J, ElSherif M, Hatchette T, McNeil S, Andrew M
Sci Rep . 2024 Aug; 14(1):18378. PMID: 39112632
We developed and validated the Influenza Severity Scale (ISS), a standardized risk assessment for influenza, to estimate and predict the probability of major clinical events in patients with laboratory-confirmed infection....
3.
McCracken G, Patriquin G, Hatchette T, Davidson R, Goodall B, Barrett L, et al.
Microbiol Spectr . 2024 Apr; 12(5):e0407323. PMID: 38567975
Importance: Rapid antigen testing for SARS-CoV-2 was widely deployed during the COVID-19 pandemic. In settings of low prevalence, national guidance recommends that positive antigen test results be confirmed with molecular...
4.
Pott H, LeBlanc J, S ElSherif M, Hatchette T, McNeil S, Andrew M
BMC Infect Dis . 2024 Jan; 24(1):147. PMID: 38291361
Background: Influenza and RSV coinfections are not commonly seen but are concerning as they can lead to serious illness and adverse clinical outcomes among vulnerable populations. Here we describe the...
5.
Murison K, Wilson C, Clow K, Gasmi S, Hatchette T, Bourgeois A, et al.
PLoS One . 2023 Dec; 18(12):e0295909. PMID: 38100405
Lyme disease cases reported in seven Canadian provinces from 2009 to 2019 through the Lyme Disease Enhanced Surveillance System are described herein by demographic, geography, time and season. The proportion...
6.
Harrison R, Mubareka S, Papenburg J, Schober T, Allen U, Hatchette T, et al.
J Assoc Med Microbiol Infect Dis Can . 2023 Dec; 8(3):176-185. PMID: 38058499
No abstract available.
7.
Renaud C, Osborn A, Parmley E, Hatchette T, LeBlanc J, Weese J, et al.
J Assoc Med Microbiol Infect Dis Can . 2023 Dec; 8(3):187-191. PMID: 38058495
Canada experienced a wave of HPAI H5N1 outbreaks in the spring of 2022 with millions of wild and farmed birds being infected. Seabird mortalities in Canada have been particularly severe...
8.
Simms E, McCracken G, Hatchette T, McNeil S, Davis I, Whelan N, et al.
Microbiol Spectr . 2023 Nov; 11(6):e0277223. PMID: 37962351
In hospitals during the COVID-19 pandemic, laboratory testing was important to reduce SARS-CoV-2 transmissions, while facilitating patient flow in the emergency department and pre-operative settings, and allowing for the safe...
9.
Pott H, Andrew M, Shaffelburg Z, Nichols M, Ye L, ElSherif M, et al.
Vaccine . 2023 Sep; 41(42):6359-6365. PMID: 37696717
Background: Influenza vaccines prevent influenza-related morbidity and mortality; however, suboptimal vaccine effectiveness (VE) of non-adjuvanted trivalent inactivated influenza vaccine (naTIV) or quadrivalent formulations in older adults prompted the use of...
10.
ElSherif M, Andrew M, Ye L, Ambrose A, Boivin G, Bowie W, et al.
Open Forum Infect Dis . 2023 Jul; 10(7):ofad315. PMID: 37441353
Background: Respiratory syncytial virus (RSV) disease in older adults is undercharacterized. To help inform future immunization policies, this study aimed to describe the disease burden in Canadian adults aged ≥50...